Ideally, this transcriptomic analysis should include mRNAs and miRNAs so that one can see ETS-1 and miR-29b increased with TET1 decreased as a subtype of cancer that could be opposed by miR-29b antagonism. The gene discussed is ETS1; the disease is cancer.